Freenome Appoints Industry Veteran Rob Guigley as Chief Commercial Officer
Freenome building commercial infrastructure following recent CLIA lab certification and early access program for key health system partners, with new test launches for colorectal cancer, lung cancer and other indications planned in 2026
In previously announced deal, Exact Sciences…
Canary Speech on TIME’s List of the World’s Top HealthTech Companies 2025
Canary Speech on TIME’s List of the World’s Top HealthTech Companies 2025
Canary Speech, the leading AI-powered voice biomarker health tech company, has been included in the first edition of the World’s...
Artera Presents AI Platform for Faster, Personalized Cancer Treatment
Artera Presents AI Platform for Faster, Personalized Cancer Treatment
Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer tests, will present four abstracts at the 2025...
Caristo Applauds Abcentra for Successful Phase 2b Trial Start
Caristo Applauds Abcentra for Successful Phase 2b Trial Start
‘FORTIFY’ Selects FAI-Score™ as Primary Outcome Measure, and Caristo as Worldwide Imaging Core Lab for Coronary Inflammation and Plaque Measurement and Monitoring...
Profusa Builds NVIDIA-Powered AI Portal for Continuous Biomarker Monitoring
Profusa Builds NVIDIA-Powered AI Portal for Continuous Biomarker Monitoring
Company expects early 2026 rollout in EEA; physician portal combines Lumee™ oxygen monitoring with NVIDIA NeMo to deliver AI-driven clinical...